Decibel Therapeutics, Inc. Proceeds from Common Stock Issued
Decibel Therapeutics, Inc. reported Proceeds from Common Stock Issued of $216.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-08-11
- Decibel Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $0.00.
- Decibel Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $216.00K.
- Decibel Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $0.00.
- Decibel Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-09-30 was $0.00.
- Decibel Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2021 was $128.24M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $216.00K 10-Q · filed 2023-08-11 | ||
| 2023-03-31 | $216.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $128.24M 10-K · filed 2023-03-14 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $128.24M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $128.24M 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $128.24M 10-Q · filed 2022-05-12 |